Gene · 566
AZU1: azurocidin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AZU1: azurocidin 1. Genes, record 566. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/566
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P20160 | Azurocidin | 251 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents57
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38556 | P20160 | Espacenet |
| US 12509511 B2 | 2025-12-30 | 6 | P20160 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 873 | P20160 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 1294 | P20160 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5554 | P20160 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5554 | P20160 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 873 | P20160 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8131 | P20160 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8132 | P20160 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 1294 | P20160 | Espacenet |
1 to 10 of 57
See all 57 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants944
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AZU1 papers | Newest fiscal year |
|---|---|---|---|
| U54GM104938 | Oklahoma Shared Clinical and Translational Resources | 6 | 2025 |
| ZIAAR041199 | Systemic Autoimmunity | 5 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30EY021725 | P30 Center Core Grant for Vision Research | 3 | 2025 |
| P51OD010425 | Washington National Primate Research Center | 3 | 2025 |
| T32AI007046 | Infectious Diseases Training Program | 3 | 2025 |
| U19AI057229 | Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | 3 | 2025 |
| ZIAHD002400 | The Role Of Subclinical Infection And Cytokines In Preterm Parturition | 3 | 2025 |
| ZIDAR041180 | Clinical Support Services for the NIAMS Intramural Research Program | 3 | 2025 |
1 to 10 of 944Source NIH's project files
See all 944 nih grantsPapers1,835
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heparin-binding protein as an emerging host-response biomarker for periprosthetic joint infection: a narrative review. | Front Cell Infect Microbiol | 2026 | 42798780 | PubTator, text mining | PubMed |
| The influence of early serum heparin-binding protein (HBP) levels on the occurrence of sepsis in patients with severe burns. | J Med Biochem | 2026 | 42769777 | PubTator, text mining | PubMed |
| Predictive Value of Heparin-Binding Protein for Organ Dysfunction and Disease Severity in Pediatric Sepsis: A Retrospective Study. | J Vis Exp | 2026 | 42730689 | PubTator, text mining | PubMed |
| Daphnetin Attenuates Inflammatory and Apoptotic Responses Induced by High Glucose/High Free Fatty Acids and Lipopolysaccharide in an HK-2 Cell-Neutrophil Co-Culture System. | Dose Response | 2026 | 42719385 | PubTator, text mining | PubMed |
| Immune Biomarker Profiling Across Clinical States and Development of a SOFA-Integrated Model for 28-Day Mortality Prediction in Sepsis: A Prospective Cohort Study. | Infect Drug Resist | 2026 | 42701808 | PubTator, text mining | PubMed |
| The Diagnostic Value of Heparin-Binding Protein for Sepsis-Associated Acute Kidney Injury: A Retrospective Single-Center Study. | Int J Gen Med | 2026 | 42633362 | PubTator, text mining | PubMed |
[Dynamic pathological mechanisms and clinical translation of thermal burns and acid corrosive injury: a multidimensional analysis based on inflammatory phases, organ damage, and coagulation disorders]. | Zhonghua Wei Zhong Bing Ji Jiu Yi Xue | 2026 | 42563677 | PubTator, text mining | PubMed |
| Heparin-Binding Protein and Transplant-Associated Inflammation: Emerging Roles in Infection, Ischemia-Reperfusion Injury, and Allograft Dysfunction. | J Clin Med | 2026 | 42513278 | PubTator, text mining | PubMed |
| Immunological Markers Associated with Postoperative Infection After Ureteroscopic Lithotripsy in Patients With Upper Urinary Tract Calculi. | J Vis Exp | 2026 | 42507652 | PubTator, text mining | PubMed |
| Reanalysis of Public Transcriptomes Reveals Shared Immune Signatures Between Major Depressive Disorder And Dermatomyositis With Single-Cell Context. | J Vis Exp | 2026 | 42441576 | PubTator, text mining | PubMed |
1 to 10 of 1,835
See all 1,835 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/566
GET https://conductscience.org/api/genes/v1/566/patents?page=2